Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Chris SenanayakeDirector | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 24/03/14 | 1,626 sh | $1.61 | $2,617.86 | −36.8% |
Milton BrownDirector | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 23/12/13 | 24/01/02 | 2,921 sh | $0.46 | $1,343.66 | −0.3% |
Bette JacobsDirector | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 23/12/13 | 23/12/20 | 4,157 sh | $0.46 | $1,912.22 | −13.3% |
Steven M. RichardsDirector | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 23/01/09 | 995 sh | $1.61 | $1,601.95 | −36.8% |
Milton BrownDirector | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 23/01/04 | 995 sh | $1.61 | $1,601.95 | −0.1% |
William AdkinsOther | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 23/01/04 | 995 sh | $1.61 | $1,601.95 | −0.5% |
Anatoly DritschiloCEO and Chairman | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 23/01/03 | 8,372 sh | $1.61 | $13,478.92 | −0.8% |
Tyvin RichChief Medical Officer | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 23/01/03 | 1,414 sh | $1.61 | $2,276.54 | −36.8% |
Mira JungChief Scientific Officer | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 23/01/03 | 328 sh | $1.61 | $528.08 | −0.0% |
Bette JacobsDirector | Shuttle Pharmaceuticals HoldingsSHPH | Open-market sale | 22/12/29 | 23/01/03 | 4,366 sh | $1.61 | $7,029.26 | −12.3% |